Product news

Share this content:
GlaxoSmithKline announced the approval of Requip XL(ropinirole extended-release tablets) in the US for the treatment of the signs and symptoms of idiopathic Parkinson's disease. The product should be available in pharmacies in mid-July 2008.
Share this content:
Scroll down to see the next article